Evidence map›Paper›PMID 38840056›Full record

ArticleBMC neurology2024

Comment on "Does the 5-2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries".

Harmen R Moes, Erik Buskens, Teus van Laar

Erratum issuedAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Harmen R MoesDepartment of Neurology, University of Groningen, University Medical Center Groningen, Groningen, 9713 GZ, The Netherlands. h.r.moes@umcg.nl.
Erik BuskensDepartment of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Teus van LaarDepartment of Neurology, University of Groningen, University Medical Center Groningen, Groningen, 9713 GZ, The Netherlands.

Funding

Parkinson Vereniging 2017-R04Universitair Medisch Centrum Groningen GR-AGIKO 18-02
6 · The paper itself

Abstract

The 5-2-1 criteria are intended to help general neurologists identify patients with advanced Parkinson's disease who may benefit from treatment optimisation, such as with a device-aided therapy. Although the 5-2-1 criteria claim to address an unmet need, we urge readers to cautiously interpret the results of this validation study.

Indexed as

Parkinson DiseaseHumans5-2-1 criteriaAdvanced Parkinson’s diseaseDevice-aided therapyPositive predictive valueValidation

Identifiers

PMID38840056
PMCPMC11151576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.